Zeng Y - Search Results

1

Pan-ERBB kinase inhibition augments CDK4/6 inhibitor efficacy in oesophageal squamous cell carcinoma.

Zhou J, Wu Z, Zhang Z, Goss L, McFarland J, Nagaraja A, Xie Y, Gu S, Peng K, Zeng Y, Zhang X, Long H, Nakagawa H, Rustgi A, Diehl JA, Meyerson M, Wong KK, Bass A. Zhou J, et al. Among authors: zeng y. Gut. 2022 Apr;71(4):665-675. doi: 10.1136/gutjnl-2020-323276. Epub 2021 Mar 31. Gut. 2022. PMID: 33789967 Free PMC article.

2

Construction and validation of "WCH-nomogram" for predicting the prognosis after resection of colorectal liver metastases.

Jiang C, Liu W, Jin Z, Lan L, Xu L, Du A, Peng S, Zeng Y, Wang H, Liao M, Zhou J. Jiang C, et al. Among authors: zeng y. Cancer Med. 2024 May;13(9):e7222. doi: 10.1002/cam4.7222. Cancer Med. 2024. PMID: 38698687 Free PMC article.

3

Surgical Management for Giant liver Hemangiomas Greater Than 20 cm in Size.

Jiang H, Chen Z, Prasoon P, Wu H, Zeng Y. Jiang H, et al. Among authors: zeng y. Gut Liver. 2011 Jun;5(2):228-33. doi: 10.5009/gnl.2011.5.2.228. Epub 2011 Jun 28. Gut Liver. 2011. PMID: 21814606 Free PMC article.

4

Current clinical uses of the biomarkers for hepatocellular carcinoma.

Huang J, Zeng Y. Huang J, et al. Among authors: zeng y. Drug Discov Ther. 2014 Apr;8(2):98-9. doi: 10.5582/ddt.8.98. Drug Discov Ther. 2014. PMID: 24815586 Free article.

5

Therapeutic efficacy of FASN inhibition in preclinical models of HCC.

Wang H, Zhou Y, Xu H, Wang X, Zhang Y, Shang R, O'Farrell M, Roessler S, Sticht C, Stahl A, Evert M, Calvisi DF, Zeng Y, Chen X. Wang H, et al. Among authors: zeng y. Hepatology. 2022 Oct;76(4):951-966. doi: 10.1002/hep.32359. Epub 2022 Feb 16. Hepatology. 2022. PMID: 35076948 Free PMC article.

6

Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients.

Li J, Yan LN, Yang J, Chen ZY, Li B, Zeng Y, Wen TF, Zhao JC, Wang WT, Yang JY, Xu MQ, Ma YK. Li J, et al. Among authors: zeng y. World J Gastroenterol. 2009 Sep 7;15(33):4170-6. doi: 10.3748/wjg.15.4170. World J Gastroenterol. 2009. PMID: 19725152 Free PMC article.

7

MicroRNAs associated with HBV infection and HBV-related HCC.

Xie KL, Zhang YG, Liu J, Zeng Y, Wu H. Xie KL, et al. Among authors: zeng y. Theranostics. 2014 Sep 19;4(12):1176-92. doi: 10.7150/thno.8715. eCollection 2014. Theranostics. 2014. PMID: 25285167 Free PMC article. Review.

8

Treatment strategy for hepatocellular carcinoma in China: radiofrequency ablation versus liver resection.

Zhu ZX, Huang JW, Liao MH, Zeng Y. Zhu ZX, et al. Among authors: zeng y. Jpn J Clin Oncol. 2016 Dec;46(12):1075-1080. doi: 10.1093/jjco/hyw134. Epub 2016 Sep 27. Jpn J Clin Oncol. 2016. PMID: 27677661 Review.

9

Prognostic significance of glypican-3 expression in hepatocellular carcinoma: A meta-analysis.

Liu H, Yang C, Lu W, Zeng Y. Liu H, et al. Among authors: zeng y. Medicine (Baltimore). 2018 Jan;97(4):e9702. doi: 10.1097/MD.0000000000009702. Medicine (Baltimore). 2018. PMID: 29369198 Free PMC article. Review.

10

Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR.

Liu H, Lan T, Li H, Xu L, Chen X, Liao H, Chen X, Du J, Cai Y, Wang J, Li X, Huang J, Yuan K, Zeng Y. Liu H, et al. Among authors: zeng y. Theranostics. 2021 Jan 1;11(3):1396-1411. doi: 10.7150/thno.53227. eCollection 2021. Theranostics. 2021. PMID: 33391541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,334 results

Search Page